State of New Jersey Common Pension Fund D Reduces Position in Waters Co. (NYSE:WAT)

State of New Jersey Common Pension Fund D decreased its holdings in Waters Co. (NYSE:WATFree Report) by 3.0% in the third quarter, Holdings Channel reports. The fund owned 33,381 shares of the medical instruments supplier’s stock after selling 1,036 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Waters were worth $9,153,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in shares of Waters by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 6,689,208 shares of the medical instruments supplier’s stock worth $2,076,263,000 after buying an additional 30,274 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Waters by 1.4% in the 3rd quarter. Bank of New York Mellon Corp now owns 3,520,629 shares of the medical instruments supplier’s stock valued at $965,392,000 after buying an additional 48,740 shares during the period. State Street Corp raised its holdings in shares of Waters by 1.2% in the 2nd quarter. State Street Corp now owns 2,619,676 shares of the medical instruments supplier’s stock valued at $698,248,000 after purchasing an additional 29,920 shares in the last quarter. Alliancebernstein L.P. raised its holdings in shares of Waters by 37.2% in the 2nd quarter. Alliancebernstein L.P. now owns 2,018,487 shares of the medical instruments supplier’s stock valued at $538,008,000 after purchasing an additional 547,777 shares in the last quarter. Finally, Wellington Management Group LLP raised its holdings in shares of Waters by 79.6% in the 1st quarter. Wellington Management Group LLP now owns 1,504,592 shares of the medical instruments supplier’s stock valued at $467,011,000 after purchasing an additional 666,851 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Wall Street Analyst Weigh In

WAT has been the topic of several research analyst reports. JPMorgan Chase & Co. cut their price target on shares of Waters from $260.00 to $250.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 8th. Citigroup boosted their price objective on shares of Waters from $265.00 to $300.00 and gave the stock a “neutral” rating in a report on Monday, December 11th. Wells Fargo & Company reduced their price target on shares of Waters from $305.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 8th. Stifel Nicolaus upped their price target on shares of Waters from $290.00 to $330.00 and gave the company a “hold” rating in a report on Wednesday, February 7th. Finally, TheStreet raised shares of Waters from a “c+” rating to a “b-” rating in a research report on Wednesday, December 13th. One analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company’s stock. According to data from MarketBeat, Waters currently has an average rating of “Hold” and an average target price of $290.38.

Check Out Our Latest Analysis on Waters

Waters Stock Down 1.2 %

Waters stock opened at $322.82 on Monday. The stock has a market cap of $19.09 billion, a price-to-earnings ratio of 29.75, a PEG ratio of 6.42 and a beta of 0.92. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 2.71. The company’s 50-day moving average price is $315.13 and its two-hundred day moving average price is $285.33. Waters Co. has a 52 week low of $231.90 and a 52 week high of $341.94.

Waters (NYSE:WATGet Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The medical instruments supplier reported $3.62 earnings per share for the quarter, beating the consensus estimate of $3.56 by $0.06. Waters had a net margin of 21.72% and a return on equity of 81.30%. The company had revenue of $819.50 million during the quarter, compared to analyst estimates of $815.50 million. During the same quarter last year, the firm posted $3.84 EPS. The business’s revenue for the quarter was down 4.5% on a year-over-year basis. On average, analysts expect that Waters Co. will post 11.89 EPS for the current fiscal year.

Waters Profile

(Free Report)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.